Addex Therapeutics Ltd ADXN
$ 7.49
-6.02%
Annual report 2023
added 11-09-2024
Country |
Schweiz |
IPO year |
- |
Industry |
- |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Mr. Timothy Dyer |
Employees in the company |
19 |
Shares |
- |
Market Cap[1] |
$ 17.7 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.